Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Authors including 'Shulgin_AT'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
LEIN OG, SHULGIN AT, GAL ... Feasibility of quantitative separation of the threo- and erythro-forms... Nature 1952
Shulgin AT Psychotomimetic amphetamines: methoxy 3,4-dialkoxyamphetamines Experientia 1964
Naranjo C, Shulgin AT, Sa... Evaluation of 3,4-methylenedioxyamphetamine MDA as an adjunct to psych... Med Pharmacol Exp In... 1967
Shulgin AT, Sargent T, Na... The chemistry and psychopharmacology of nutmeg and of several related ... Psychopharmacol Bull 1967
Shulgin AT, Sargent T, Na... Structure--activity relationships of one-ring psychotomimetics Nature 1969
Shulgin AT Mescaline: the chemistry and pharmacology of its analogs Lloydia 1973
Shulgin AT Sterospecific requirements for hallucinogenesis J. Pharm. Pharmacol. 1973
Shulgin AT, Carter MF Centrally Active Phenethylamines Psychopharmacology C... 1975
Shulgin AT, Helisten C Differentiation of PCP, TCP, and a contaminating precursor PCC, by thi... Microgram 1975
Braun U, Shulgin AT, Brau... Synthesis and Body Distribution of Several Iodine-131 Labeled Centrall... Journal of Medicinal... 1977
Anderson GM 3d, Braun G, ... Absolute configuration and psychotomimetic activity NIDA Res Monogr 1978
Shulgin AT, Nichols DE Characterization of three new psychotomimetics. The Pharmacology of Ha... The Psychopharmacolo... 1978
Braun U, Braun G, Jacob P... Mescaline analogs: substitutions at the 4-position NIDA Res Monogr 1978
Murdock JE, Shulgin AT A novel illicit amphetamine laboratory Microgram 1978
Shulgin AT Chemistry of phenethylamines related to mescaline J Psychedelic Drugs 1979
Carter MF, Shulgin AT N,N-Diisopropyltryptamine (DIPT) and 5-methoxy-N,N-diisopropyltryptami... Commun Psychopharmac... 1980
Braun U, Shulgin AT, Brau... Centrally active N-substituted analogs of 3,4- methylenedioxyphenyliso... J Pharm Sci 1980
Domelsmith LN, Eaton TA, ... Photoelectron spectra of psychotropic drugs. 6. Relationships between ... J Med Chem 1981
Repke DB, Grotjahn DB, Sh... Psychotomimetic N-methyl-N-isopropyltryptamines. Effects of variation ... J Med Chem 1985
Lemaire D, Jacob P, Shulg... Ring-substituted beta-methoxyphenethylamines: a new class of psychotom... J Pharm Pharmacol 1985
Shulgin AT, Shulgin LA, J... A protocol for the evaluation of new psychoactive drugs in man Methods Find Exp Cli... 1986
Shulgin AT The background and chemistry of MDMA J Psychoactive Drugs 1986
Nichols DE, Hoffman AJ, O... Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives ... J Med Chem 1986
Cozzi NV, Sievert MK, Shu... Methcathinone and 2-methylamino-1-(3,4-methylenedioxyphenyl)propan-1-o... Soc. Neurosci. Abs 1988
McKenna DJ, Guan XM, Shul... 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential eff... Pharmacol Biochem Be... 1991
Galloway G, Shulgin AT, K... Amphetamine, not MDMA, is associated with intracranial hemorrhage J Accid Emerg Med 1995
Parker MA, Marona-Lewicka... Synthesis and pharmacological evaluation of ring-methylated derivative... J Med Chem 1998
Cozzi NV, Shulgin AT, Ruo... Methcathinone (MCAT) and 2-methylamino-1-(3,4-methylenedioxyphenyl)pro... Amer. Chem. Soc. Div... 1998
Cozzi NV, Sievert MK, Shu... Inhibition of plasma membrane monoamine transporters by beta-ketoamphe... Eur J Pharmacol 1999